Recently, Gόmez-Abenza and colleagues discovered that serine peptidase inhibitor, Kunitz type 1 (SPINT1) regulated melanoma aggression and crosstalk in the tumor microenvironment [101]. This evidence concerns the gene SPINT1 and melanoma.